반응식
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[NH2:17][C:18]1[CH:23]=[CH:22][C:21]([O:24][CH3:25])=[CH:20][CH:19]=1>>[CH3:25][O:24][C:21]1[CH:22]=[CH:23][C:18]([NH:17][C:1](=[O:10])[C:2]2[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=2)[OH:4])=[CH:19][CH:20]=1참가 물질
3
실험 절차
The 4′-methoxy-salicylanilide was prepared by condensing phenyl salicylate with 4-aminoanisole then purified as described in Example 2a. The mixture of ligands was then prepared from 4′-methoxy-salicylanilide and 1,1′-bi-2-naphthol using the procedure described in Example 5a. 31P NMR (121.77 MHz): several peaks between 116-118 ppm.
후처리
- customthen purified
- additionThe mixture of ligands
- customwas then prepared from 4′-methoxy-salicylanilide and 1,1′-bi-2-naphthol using the procedure
출처 및 근거
- ORD 기록
- ord-2fd168cee4a14c97a4b946f0e3f1930d
- 출처 데이터셋
- uspto-grants-2003_12
- 특허 번호
- US06664427B1
연결된 노트
불러오는 중…